NH Medicaid dropped GLP-1 weight-loss coverage on January 1, 2026. Here’s the cash-pay landscape for New Hampshire residents in 2026 — telehealth eligibility, real prices from $129 to $1,349/mo, compounded vs FDA-approved trade-offs, and where PlexusDx Weight Management Protocols fit.

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth. Kentucky Medicaid does not cover GLP-1 for weight loss. PlexusDx Weight Management Protocols ship to all 120 Kentucky counties from $129/mo flat with no membership fee.

The full 2026 GLP-1 cost map: Wegovy, Ozempic, Zepbound, and Mounjaro at branded list price; Lilly Direct and NovoCare manufacturer self-pay programs ($149–$499/mo); cash-pay compounded telehealth alternatives. PlexusDx Weight Management Protocols span $129–$509/mo with all-inclusive pricing, no membership, all 50 states.

Foundayo's $149 headline is a one-month starter price — the real cash-pay year runs $3,338–$3,738 once you escalate. Compare PlexusDx Microdose GLP-1 ($129/mo flat), Semaglutide Oral ($209+/mo), and Tirzepatide Oral ($229+/mo) on annualized cost.

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149–$349/month self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $179–$229/mo, Tirzepatide Injection $229–$309/mo — with no membership fee.

Eden semaglutide reviews reveal flat-dose pricing strengths, BBB complaint friction, and four published price points across Eden's own pages. Compare Eden's compounded semaglutide with PlexusDx Semaglutide Injection ($179–$229/mo), Microdose GLP-1 ($129/mo flat), and Semaglutide Oral (from $209/mo) — cash-pay, no membership, with optional genetic-test dose personalization.

Eden vs Ro vs PlexusDx for cash-pay GLP-1 weight loss in 2026: real annualized cost math on Eden’s $129–$329/mo all-inclusive compounded plans, Ro’s $149/mo membership plus FDA-approved branded medication (Wegovy, Zepbound, Ozempic, Foundayo), and PlexusDx Weight Management Protocols from $129/mo — with the Precision Peptide Genetic Test as a $99 add-on so dosing is anchored to GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants before week one.

Eden cancellation policy explained: $0 fee, no contract, but refunds hinge on the pharmacy cutoff. Step-by-step portal and email cancellation, prepaid 3-month plan rules, medical-reason refund path, and how PlexusDx month-to-month protocols ($129–$509/mo, no membership, all 50 states) sidestep the cutoff problem.

MEDVi’s compounded plans bundle medication and platform into one price (no separate membership fee); branded Wegovy/Zepbound paths add a $99/mo membership. We reconcile MEDVi’s fee structure, the 28-day billing cycle, and where PlexusDx Weight Management Protocols sit at $129–$325/mo with no membership fee on any tier.

Compare the best online tirzepatide providers in 2026 — Ro, Eden, Yucca Health, Willow, Sesame — against the PlexusDx Tirzepatide Injection ($229–$309/mo) and Tirzepatide Oral ($229–$509/mo) Protocols, with a genetic baseline option no other provider offers.

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $179–$229/mo.

How PlexusDx Weight Management Protocols compare to the major cash-pay GLP-1 programs in 2026 — Mochi, Eden, MEDVi, Ro, GoodRx Care Direct, NovoCare, and LillyDirect — on price, medication source, membership fees, and total annualized cost.

Compounded tirzepatide provider rankings cycle through MEDVi, Eden, Yucca Health, Willow, and Trim RX. PlexusDx Tirzepatide Injection ($229–$309/mo) and Tirzepatide Oral ($229–$509/mo) compare on price, oversight, and genetic-test personalization.

503A vs 503B compounding pharmacy explained — the regulatory framework, FDA Modernization Act of 1997 and Drug Quality and Security Act of 2013, oversight differences, and a five-step verification checklist for compounded GLP-1 medications.

Are GLP-1 pills safe? Four are FDA-approved in 2026 (Rybelsus, Ozempic tablets, Wegovy tablet, Foundayo). Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category. No-prescription drops and gummies aren't legitimate. Here's the safety framework, the boxed-warning context, and where PlexusDx oral protocols fit.

A buyer-side read of the seven brand-name GLP-1 telehealth providers (Ro, Walgreens, GoodRx, Hims & Hers, PlushCare, Sesame, WeightWatchers) covering true month-one cost, what each dispenses, and how PlexusDx compounded protocols ($129–$325/mo, all-inclusive, no membership) fit when branded coverage isn't accessible.

How to verify a 503A compounding pharmacy before ordering compounded semaglutide or tirzepatide: eight automatic walk-away triggers, a 10-minute audit using state-board, FDA, PCAB, and NABP databases, and where PlexusDx Weight Management Protocols sit in that framework.

No FDA-approved generic Tirzepatide exists as of April 2026. This article explains why (patent exclusivity and the biosimilar pathway), what "generic Tirzepatide" typically means in consumer search, legitimate compounded alternatives through licensed pharmacies, and PlexusDx Weight Management Protocols as a published-price option.

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.

Mounjaro 15 mg is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the 15 mg dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

Tirzepatide 10 mg is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the 10 mg dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.

Mounjaro access as of April 2026: this article covers the legitimate prescribing pathway, how telehealth evaluation works, red flags for unauthorized sellers, compounded alternatives through licensed 503A pharmacies, and PlexusDx Weight Management Protocols with provider evaluation included.

No FDA-approved generic Tirzepatide exists as of April 2026. This article explains why (patent exclusivity and the biosimilar pathway), what "generic Tirzepatide" typically means in consumer search, legitimate compounded alternatives through licensed pharmacies, and PlexusDx Weight Management Protocols as a published-price option.

Tirzepatide 5 mg is one step in the FDA-approved dose-titration schedule for this compound. This article reports what the label says about the 5 mg dose, common patient experiences at this step, when the next step typically happens, and the GLP-1 pathway genetics underneath every dose decision.

Mounjaro is a GLP-1 pathway compound relevant to weight management through its effects on appetite, satiety, and metabolism. This article covers mechanism, clinical trial evidence, FDA-approved indications, boxed-warning safety, and the FTO, GLP1R, MC4R, and TCF7L2 variants that shape every GLP-1 response.

Mounjaro oral options as of April 2026: this article explains what formats are FDA-approved, how oral and injection forms compare on bioavailability and dosing, what administration requires, and the PlexusDx Weight Management Protocols that offer both oral and injection options.

Mounjaro oral options as of April 2026: this article explains what formats are FDA-approved, how oral and injection forms compare on bioavailability and dosing, what administration requires, and the PlexusDx Weight Management Protocols that offer both oral and injection options.

Mounjaro list price is approximately $1,069 per month at U.S. list price as of April 2026 (Eli Lilly published pricing). This article covers insurance coverage, manufacturer savings programs, compounded alternatives, and PlexusDx Weight Management Protocols as of April 2026.